DIMA Biotech specializes in expressing and purifying membrane proteins using mammalian cells. Our extensive inventory Presented By: François Romagné Speaker Biography: Professor of immunotechnology at Aix-Marseille University (AMU),
Scientist Stories: Andrew Kruse, GPCRs & Antibody Discovery Antibody discovery in weeks versus years - Isolate, culture, and assay tens of thousands of single cells with the Beacon platform
In this webinar, Dr. Marayna Löwe and Dr. Mathieu Schaff will provide valuable knowledge and practical insights into copolymers Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain SLC2A4 glucose transporter (GLUT4 )
PEGS Virtual 2020 Presentation: Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies High Throughput Characterization of Ion Channel Activity Blocking mAbs with Array SPR | LSA Platform
Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs. To exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the
Immunogens with native conformation and a high-throughput IgG cloning platform are two of the most important key components Antibodies Against Membrane Protein Targets | Discovery on Target
PRODUCT: Opto Plasma B Discovery 4.0 Product Tour Integrated antibody discovery solution for multi-pass transmembrane target
Targeting membrane proteins for antibody discovery using phage Membrane Protein Antibody Discovery, MPS AB5000 | Kyinno Bio Spotlight on Antibodies | Episode 7 | July 1 - 31, 2025
The discovery and challenges of antibodies targeting GPCRs Breaking barriers in antibody discovery: harnessing divergent
Discovery Challenges & Strategies - Targeting Membrane Proteins Presented by Carterra and Bio-Techne The COVID-19 pandemic and global effort around vaccine development has heightened Join us live for our webinar, in collaboration with Drug Target Review. Our Chief Technology Officer, Xavier Leroy and Martine
2025-08-21-DIMA: The Application of Synthetic Nanodisc Technology in Therapeutic Antibody Discovery Looking to streamline your biomarker discovery process? In this video, we dive deep into Assay Genie's Membrane Antibody
DISCOVER pure protein-DNA conjugates: preparation, purification, and analysis with the proFIRE® In this webinar, we introduce single cell technology in immunology and antibody screening, including its emergence, various Webinar: AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution Speaker: Gang Liu, Ph.D., Associate
Generating protein reagents to evaluate the antibody and CD8+ T cell responses to SARS-CoV-2 Abstract Transmembrane proteins usually play pivotal roles in various cellular processes, including signal transduction, cell The development of antibody drugs has greatly depended on the establishment of new technologies and platforms, which are
[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies Webinar: Best Practices for Antibody Specificity Testing for IND Submissions
Dispensable loops shield the functionally-important extracellular loops of the essential Gram-negative bacterial outer membrane protein LptD Webinar: AbDrop™: Accelerating Your Antibody Discovery with Single B Solution | 2025 PEGS Boston Virtual 2020 Presentation: De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben
Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning polypeptides, encompass families Cracking Protein Structures: From Cryo-EM to Antibody Discovery – A Webinar with Dr. Krishna Bhat
Part 1: Identification of Monoclonal Antibodies that Block Ion Channel Activity Learn how Tetragenetics has developed a strategy Discovery On Target 2020: Isolation of state-dependent monoclonal antibodies against GLUT4 The MPS Discovery Engine® enables the isolation of monoclonal antibodies targeting complex membrane proteins. Click here to learn more.
Massive antibody discovery used to probe structure–function Lessons in Generating Monoclonal Antibodies against Multipass Membrane Proteins- Ross Chambers, PhD
This is the fourth episode of our DISCOVER MOLECULAR INTERACTIONS webinar series. Each month we will talk about 6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins To help Biopharm accelerate its pace on pre-clinical antibody drug lead selection, DIMA Biotech launched an “All Druggable
De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD Discovery of Therapeutic Antibodies Targeting Complex Multi
Webinar "Next Gen P2X4 Antibody Discovery Enabled by the NativeMP+Phage Display Technology " Join us for an exclusive session with Dr. Krishna Bhat, Principal Scientist at IONLACE and former researcher at Umeå University
Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets | DIMA Biotech @ CAS 2025 Protein Science in Drug Discovery Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb)
Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array Stabilization of native & functional membrane proteins for drug discovery
Take a tour of our latest antibody discovery workflow, Opto Plasma B Discovery 4.0. Antibody Discovery | Integral Molecular Dr Sachdev Sidhu
Accelerate COVID19 Antibody Discovery With ProSpeed Single B Cell Technology Spotlight on Antibodies is a podcast from Biointron ( , where we bring you the latest antibody
Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Anass Jawhari, PhD - Chief Scientific Officer, CALIXAR Originally presented at the Antibody Engineering & Therapeutics Digital Week on June 8-10, 2020. Watch this and the other
Antibody drug development challenges & solutions Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to Webinar: Conquering Undruggable Targets to Obtain Preclinical Antibodies This webinar assembles experts in antibody discovery and development and features presentations from Integral Molecular,
Despite the remarkable growth of antibody-based therapies in recent years, numerous promising targets remain untapped. COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA Platform
Improve therapeutic monoclonal antibody selection by knowing protein stability using Prometheus Presented By: Natalia Guadalupe Herrera Speaker Biography: My name is Natalia Guadalupe Herrera and I obtained a BS in Transient expression is a fast and reliable way to generate recombinant antibodies and proteins (i.e. products) for all research
Speakers: Andrew Hunt, Phd Student, Northwestern University Alex Pierson, Technical Product Manager for the Access Solutions ChemPartner Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets
Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets Improving Drug Discovery: A Molecular Understanding of Cell Receptors (Short) Accelerating Antibody Discovery with Cell Free Protein Synthesis and Automation
Protein Science in Drug Discovery Moderators: Vanita D. Sood, EMD Serono & Christopher Koth, Genentech Speakers: Patrick Signal transduction across cell membranes plays a central role in human physiology and disease, yet the mechanistic details TARGATT A Mammalian Cell Library System for Antibody Protein Screening
Webinar: Uni-Select™ Mammalian Cell-Based Membrane Proteins Antibody Screening Applied StemCell provides Custom The 13th Annual Antibodies Against Membrane Protein Targets brings together leading researchers and industry innovators to tackle the unique challenges and Antibody Validation 08: Protein arrays and mass spectrometry
Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Jon Zmuda, PhD - Director, Cell Biology, Life Sciences Antibody discovery at the edge of impossible This is the second episode of the second season of the DISCOVER MOLECULAR INTERACTIONS webinar series. Each month
Review: Membrane protein nanodiscs for antibody discovery De Novo Design of Epitope-Specific Antibodies for Membrane Proteins with High Specificity & Function
Unlocking Biomarker Discovery with Multiplex Antibody Membrane Arrays 🚀 | Assay Genie Speaker: Dr. Nathan Robertson I Group Leader — Antibody Discovery/Protein Engineering I OXGENE Antibody screening using The successful isolation of antibodies from a naive scFv library is described for three membrane bound proteins; human CD83, canine CD117 and bat CD11b.
Sino Biological is a leading manufacturer of recombinant proteins and antibodies. In addition to our biggest validated recombinant This presentation, delivered at CAS 2025 and presented by DIMA Biotech, highlights our proprietary platform for the discovery of
Discovery of Potent anti-PD-L1 Antibodies | High-Throughput Antibody Screening | LSA Platform Overview of the CRO Service Platforms for Recombinant Protein Expression and Antibody Development
Advancements in AI are revolutionizing antibody design, enabling the creation of epitope-specific antibodies with exceptional David MacMillan: A “flashlight” to identify cellular proteins for drug discovery MPSA-AB5000 is a high-throughput cell-based platform for identifying the targets of antibodies and other ligands that bind to membrane proteins.
DISCOVER complex membrane targets: measure binding to GPCRs, ion channels and more directly on cells Webinar - New Ways to Boost Recombinant Protein and Antibody Yields in Transient Systems
Visit the Proteomics Analytics Resource Center: In this webinar, Jeffrey Silva, PhD, Principal Everyday researchers face the daunting challenge of creating more effective biotherapeutics. Many candidates fail due to a lack of The human animal is multicellular – an organism comprised of trillions of smaller organisms. As with any complex organisation,
Targeting Transmembrane Proteins: Facilitating Rapid Advancement in Therapeutic Antibody Discovery This review discusses various membrane protein nanodiscs, and their applications in antibody discovery, alongside current advancements and challenges.
Revolutionizing Drug Development: Synthetic Nanodiscs Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane Therapeutic lead antibody discovery and solutions
The current review focuses on the ways in which therapeutic antibody discovery and development technologies are evolving the possibilities for antibody-based Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion
Dr. Mike Taussig, Cambridge Protein Arrays, and Dr. Fridtjof Lund-Johansen, Oslo University Hospital, look at array and Antibody Therapies Targeting Complex Membrane Proteins A technology for illuminating proteins on the cell surface promises to boost the success of drug discovery, aid in basic research,
Latest Developments in High Titer Transient Protein Expression using the ExpiCHO Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t Complexities of using membrane proteins as antigens in antibody drug discovery, intrinsic challenges & innovative strategies for success.
Multiple Innovative Technologies & Platforms Empower Antibody Discovery Presented By: Dr. Donghui Ma Speaker Biography: Dr. Donghui Ma, an accomplished biotechnology pioneer, serves as the